BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32332143)

  • 1. MITIGATE-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics, and Preliminary Imaging of
    Gruber L; Jiménez-Franco LD; Decristoforo C; Uprimny C; Glatting G; Hohenberger P; Schoenberg SO; Reindl W; Orlandi F; Mariani M; Jaschke W; Virgolini I
    J Nucl Med; 2020 Dec; 61(12):1749-1755. PubMed ID: 32332143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 68Ga/177Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology.
    Dalm SU; Bakker IL; de Blois E; Doeswijk GN; Konijnenberg MW; Orlandi F; Barbato D; Tedesco M; Maina T; Nock BA; de Jong M
    J Nucl Med; 2017 Feb; 58(2):293-299. PubMed ID: 27609789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging Properties and Tumor Targeting of
    Gruber L; Decristoforo C; Uprimny C; Hohenberger P; Schoenberg SO; Orlandi F; Mariani MF; Manzl C; Kasseroler MT; Tilg H; Zelger B; Jaschke WR; Virgolini IJ
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36428467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results.
    Nock BA; Kaloudi A; Lymperis E; Giarika A; Kulkarni HR; Klette I; Singh A; Krenning EP; de Jong M; Maina T; Baum RP
    J Nucl Med; 2017 Jan; 58(1):75-80. PubMed ID: 27493272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Translation of a Dual Integrin αvβ3- and Gastrin-Releasing Peptide Receptor-Targeting PET Radiotracer, 68Ga-BBN-RGD.
    Zhang J; Niu G; Lang L; Li F; Fan X; Yan X; Yao S; Yan W; Huo L; Chen L; Li Z; Zhu Z; Chen X
    J Nucl Med; 2017 Feb; 58(2):228-234. PubMed ID: 27493267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET Using a GRPR Antagonist
    Zhang J; Niu G; Fan X; Lang L; Hou G; Chen L; Wu H; Zhu Z; Li F; Chen X
    J Nucl Med; 2018 Jun; 59(6):922-928. PubMed ID: 29123014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imaging.
    Gourni E; Mansi R; Jamous M; Waser B; Smerling C; Burian A; Buchegger F; Reubi JC; Maecke HR
    J Nucl Med; 2014 Oct; 55(10):1719-25. PubMed ID: 25146125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 68Ga-NOTA-Aca-BBN(7-14) PET/CT in Healthy Volunteers and Glioma Patients.
    Zhang J; Li D; Lang L; Zhu Z; Wang L; Wu P; Niu G; Li F; Chen X
    J Nucl Med; 2016 Jan; 57(1):9-14. PubMed ID: 26449838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron Emission Tomography Imaging of the Gastrin-Releasing Peptide Receptor with a Novel Bombesin Analogue.
    Lau J; Rousseau E; Zhang Z; Uribe CF; Kuo HT; Zeisler J; Zhang C; Kwon D; Lin KS; Bénard F
    ACS Omega; 2019 Jan; 4(1):1470-1478. PubMed ID: 30775647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [⁶⁸Ga]SB3 and PET/CT.
    Maina T; Bergsma H; Kulkarni HR; Mueller D; Charalambidis D; Krenning EP; Nock BA; de Jong M; Baum RP
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):964-973. PubMed ID: 26631238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, Biodistribution, and Radiation Dosimetry of
    Nicolas GP; Beykan S; Bouterfa H; Kaufmann J; Bauman A; Lassmann M; Reubi JC; Rivier JEF; Maecke HR; Fani M; Wild D
    J Nucl Med; 2018 Jun; 59(6):909-914. PubMed ID: 29025985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer.
    Chatalic KL; Franssen GM; van Weerden WM; McBride WJ; Laverman P; de Blois E; Hajjaj B; Brunel L; Goldenberg DM; Fehrentz JA; Martinez J; Boerman OC; de Jong M
    J Nucl Med; 2014 Dec; 55(12):2050-6. PubMed ID: 25413139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GRPr Antagonist
    Bakker IL; Fröberg AC; Busstra MB; Verzijlbergen JF; Konijnenberg M; van Leenders GJLH; Schoots IG; de Blois E; van Weerden WM; Dalm SU; Maina T; Nock BA; de Jong M
    J Nucl Med; 2021 Nov; 62(11):1517-1523. PubMed ID: 33789933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Gastrointestinal Stromal Tumor with
    Paulmichl A; Summer D; Manzl C; Rangger C; Orlandi F; Niedermoser S; Taguchi T; Wängler B; Decristoforo C
    Cancer Biother Radiopharm; 2016 Oct; 31(8):302-310. PubMed ID: 27754750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of biological properties of [
    Rousseau E; Lau J; Zhang Z; Zhang C; Kwon D; Uribe CF; Kuo HT; Zeisler J; Bratanovic I; Lin KS; Bénard F
    J Labelled Comp Radiopharm; 2020 Feb; 63(2):56-64. PubMed ID: 31715025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26.
    Varasteh Z; Mitran B; Rosenström U; Velikyan I; Rosestedt M; Lindeberg G; Sörensen J; Larhed M; Tolmachev V; Orlova A
    Nucl Med Biol; 2015 May; 42(5):446-454. PubMed ID: 25684649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor-Positive Prostate Cancer.
    Bratanovic IJ; Zhang C; Zhang Z; Kuo HT; Colpo N; Zeisler J; Merkens H; Uribe C; Lin KS; Bénard F
    J Nucl Med; 2022 Mar; 63(3):424-430. PubMed ID: 34301778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiometal Complexes as Pharmacokinetic Modifiers: A Potent
    Schreck MV; Burgard C; Schmidtke A; Hierlmeier I; Stemler T; Maus S; Rosar F; Jung M; Speicher A; Ezziddin S; Holland JP; Bartholomä MD
    Mol Pharm; 2023 Dec; 20(12):6463-6473. PubMed ID: 37978936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist.
    Zhang H; Desai P; Koike Y; Houghton J; Carlin S; Tandon N; Touijer K; Weber WA
    J Nucl Med; 2017 Jan; 58(1):29-35. PubMed ID: 27516447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.